berbamine has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, JB; Cao, Y; Liu, LL; Yan, JD; Yu, BB | 1 |
| Gan, Y; Huang, W; Li, T; Lou, G; Ma, X; Meng, Z; Tang, J; Van Ness, C; Wang, X; Wang, Y; Wu, J; Xu, R; Yen, Y; Zhou, H | 1 |
| Dong, QH; Lü, QH; Wang, GY; Xu, RZ; Zhang, JW | 1 |
3 other study(ies) available for berbamine and Cancer of Liver
| Article | Year |
|---|---|
Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism.
Topics: Benzylisoquinolines; Cell Proliferation; Connexins; Dose-Response Relationship, Drug; Gap Junction beta-1 Protein; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt | 2022 |
Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.
Topics: Animals; Apoptosis; Benzylisoquinolines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Xenograft Model Antitumor Assays | 2013 |
Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation.
Topics: Alkaloids; Apoptosis; Benzylisoquinolines; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Enzyme Activation; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Membrane Potentials; Mitochondria, Liver | 2007 |